| || |
|RX COMMUNICATIONS GROUP EXPANDS CANADIAN PRESENCE
WITH ADDITION OF TWO NEW CLIENTS
FOR INQUIRIES CONTACT
Pete Holmberg, Vice President Media Relations
Rx Communications Group, LLC
RX COMMUNICATIONS GROUP EXPANDS CANADIAN PRESENCE
WITH ADDITION OF TWO NEW CLIENTS
DRAXIS Health, Inc. and Theratechnologies Inc. Retain Rx Communications as Investor Relations Counsel
NEW YORK, NY, FEBRUARY 23, 2004 – Rx Communications Group, LLC, a financial communications firm specializing in the life science and healthcare industries, today announced that the firm has been retained by DRAXIS Health Inc. (Nasdaq: DRAX; TSX: DAX) and Theratechnologies Inc. (TSX: TH) for investor relations counsel in the United States. The addition of these accounts marks Rx’ expansion into the Canadian market, following the opening of the Company’s Toronto satellite office in September 2003.
Commenting on today’s news, Rhonda Chiger, co-President of Rx Communications Group, noted, “In building a presence in this market, our niche will be to work closely with Canadian companies as they seek to increase their exposure to the U.S. financial markets. Our goals on behalf of DRAXIS Health and Theratechnologies, though tailored specifically to fit their needs, will focus on improving the visibility, shareholder base and coverage of both firms among key U.S. institutional investors and sell-side analysts, as well as within the financial media community. We are delighted to be working with these companies and look forward to long and lasting relationships with both.”
Melody A. Carey, co-President of Rx Communications Group, said, “We have been working diligently to expand our already well-regarded international client base into the Canadian marketplace, and with the addition of DRAXIS Health and Theratechnologies, we have made a strong start. Our Canadian outreach initiatives have been in direct response to the growing interest among companies there seeking to tap into the high level of specialization within the U.S. markets. For Canadian companies dedicated to the life sciences, the U.S. financial community offers a greater level of understanding and, potentially, a greater valuation. We believe that our full service approach, coupled with our RxIR USAÒ service -- for companies with minimum resources that wish to gain a higher profile in the States -- will provide Canadian firms at all stages of development with an ability to build a meaningful presence in the U.S. market.”
DRAXIS Health Inc., located in Mississauga, Ontario, is a specialty pharmaceutical company involved in the development, production, marketing and distribution of therapeutic and diagnostic radiopharmaceuticals through DRAXIMAGE Inc. and in the provision of pharmaceutical contract manufacturing services, specializing in liquid and freeze-dried injectables and other sterile products, through DRAXIS Pharma Inc.
Theratechnologies Inc., located in St. Laurent, Québec, is a biotechnology company engaged in the discovery and development of therapeutic products in the field of endocrinology and metabolism. The company has and is developing a portfolio of peptides at various stages of development for the treatment of catabolic (loss of the body's synthesis and regeneration capacity) and metabolic disorders, as well as osteoporosis and type II diabetes. In addition, Theratechnologies is expanding its peptide portfolio through proven, proprietary technologies. Its subsidiary, Celmed BioSciences, develops cell-based therapies.
Rx Communications Group, LLC is a financial communications firm specializing in the life science and healthcare industries. Rx provides investor relations, media relations and corporate communications counsel to private and public companies, worldwide. The firm designs, implements and manages full-service programs, and handles transaction-oriented assignments. Rx executives are well versed in IPOs, secondary offerings, PIPEs, venture rounds and mergers and acquisitions. RxIR USAÒ is a service of Rx Communications geared toward non-U.S. listed public foreign companies seeking to reach U.S. investors. For more information about Rx Communications, visit the company’s website at http://www.RxIR.com.